Rabeprazole (Rabeprazole) is classified as a proton pump inhibitor (PPI). Rabeprazole sodium delayed-release tablets are indicated for short-term (4 to 8 weeks) treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease (GERD)
